Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has a beta value of 1.27 and has seen 9,041,344 shares traded in the recent trading session. The company, currently valued at $33.57 Million, closed the recent trade at $0.6165 per share which meant it lost $0 on the day or 2.26% during that session. The TNXP stock price is -2414.19% off its 52-week high price of $15.5 and 36.74% above the 52-week low of $0.39. If we look at the company’s 10-day average daily trading volume, we find that it stood at 14.24 Million shares traded. The 3-month trading volume is 7.29 Million shares.

The consensus among analysts is that Tonix Pharmaceuticals Holding Corp. (TNXP) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.22.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) trade information

Sporting 2.82% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the TNXP stock price touched $0.66 or saw a rise of 7.2%. Year-to-date, Tonix Pharmaceuticals Holding Corp. shares have moved -47.65%, while the 5-day performance has seen it change -1.21%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) have changed -5.77%. Short interest in the company has seen 751.62 Million shares shorted with days to cover at 103.1.

Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could jump 305.52% from current levels. The projected low price target is $2.5 while the price target rests at a high of $2.5. In that case, then, we find that the current price level is +305.52% off the targeted high while a plunge would see the stock lose 305.52% from current levels.

Tonix Pharmaceuticals Holding Corp. (TNXP) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +92.8% while over the next 5 years, the company’s earnings are expected to increase by 0%.